2-anilinotriazines as CRH(1) receptor antagonists.

被引：0

作者：

Christos, TE ^{[1
]}

Arvanitis, AG ^{[1
]}

Beck, J ^{[1
]}

Cheeseman, RS ^{[1
]}

Chorvat, RJ ^{[1
]}

Cocuzza, AJ ^{[1
]}

Culp, S ^{[1
]}

Gilligan, PJ ^{[1
]}

Hartig, PR ^{[1
]}

Hobbs, F ^{[1
]}

Klaczkiewicz, J ^{[1
]}

Krenitsky, P ^{[1
]}

Scholfield, E ^{[1
]}

Wilde, RG ^{[1
]}

Zaczek, R ^{[1
]}

机构：

[1] DUPONT MERCK PHARMACEUT CO,EXPT STN,WILMINGTON,DE 19880

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1996年 / 212卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：92 / MEDI

页数：1

共 50 条

[31] Benzodiaziepines as potent and selective bradykinin B1 receptor antagonists.
Kim, JJ
Wood, MR
DiPardo, RM
Dorsey, BD
Han, W
Ransom, RW
Murphy, KL
Harrell, CM
Chang, RSL
Miller, PJ
O'Malley, SS
Lis, EV
Reiss, DR
Ellis, JD
Pettibone, DJ
Freidinger, RM
Bock, MG
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U211 - U211
[32] The design, binding affinity prediction and synthesis of macrocyclic angiotensin II AT(1) and AT(2) receptor antagonists.
deLaszlo, SE
Glinka, TW
Greenlee, WJ
Ball, R
Nachbar, RB
Prendergast, K
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (08) : 923 - 928
[33] Molecular modeling of lysophosphatidic acid receptor antagonists.
Sardar, VM
Virag, T
Fischer, DJ
Elrod, D
Bautista, DL
Wang, DA
Nusser, N
Yokoyama, K
Baker, DL
Miller, DD
Tigyi, G
Parrill, AL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U19 - U19
[34] Development and therapeutic role of glutamate receptor antagonists.
Leeson, PD
Sharp, M
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 104 - MEDI
[35] Cyclic imides as potent and selective α-1a adrenergic receptor antagonists.
DiPardo, RM
Patane, MA
Price, RP
Newton, RC
DiSalvo, J
Broten, TP
Chang, RSL
Ransom, RW
Freidlinger, RM
Bock, MG
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U589 - U589
[36] NR2B subtype selective NMDA receptor antagonists.
McCauley, JA
Claiborne, CF
Theberge, CR
Romano, JJ
Billings, SB
Libby, BE
McIntyre, CJ
Anderson, KD
Michelson, SR
Claremon, DA
Freidinger, RM
Bednar, RA
Mosser, SD
Gaul, SL
Connolly, TM
Condra, CL
Xia, M
Cunningham, ME
Kiss, L
Bednar, B
Stump, GL
Lynch, JJ
Curtis, NR
Diggle, HJ
Kulagowski, JJ
Macaulay, A
Wafford, KA
Koblan, KS
Liverton, NJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U37 - U37
[37] Novel melanin concentrating hormone receptor antagonists.
Ma, VV
Balan, C
Tempest, PA
Hulme, C
Bannon, T
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U67 - U67
[38] Discovery of novel human glucagon receptor antagonists.
Shen, DM
Zhang, F
Brady, EJ
Candelore, MR
Ding, VDH
Jiang, G
Mock, S
Qureshi, SA
Saperstein, R
Tamvakopoulos, C
Tong, X
Tota, LM
Wright, M
Zheng, S
Chapman, KT
Zhang, BB
Tata, JR
Parmee, E
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U121 - U121
[39] Benzylidene ketal derivatives as M2 muscarinic receptor antagonists.
Boyle, CD
Chackalamannil, S
Chen, LY
Dugar, S
Pushpavanam, P
Billard, W
Binch, H
Crosby, G
Coffin, VL
Cohen-Williams, M
Duffy, RA
Ruperto, V
Taylor, LA
McQuade, RD
Lachowicz, JE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U556 - U556
[40] Biphenyls as potent vitronectin receptor antagonists.: Part 2:: Biphenylalanine ureas
Urbahns, K
Härter, M
Vaupel, A
Albers, M
Schmidt, D
Brüggemeier, U
Stelte-Ludwig, B
Gerdes, C
Tsujishita, F
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (06) : 1071 - 1074

← 1 2 3 4 5 →